Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR12742]
- RabMAb
- Recombinant
- KO Validated
- Advanced Validation
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal KDM5A / Jarid1A / RBBP2 antibody. Suitable for IP, WB, Flow Cyt (Intra), ChIC/CUT&RUN-seq and reacts with Mouse, Human samples. Cited in 1 publication.
View Alternative Names
JARID1A, RBBP2, RBP2, KDM5A, Lysine-specific demethylase 5A, Histone demethylase JARID1A, Jumonji/ARID domain-containing protein 1A, Retinoblastoma-binding protein 2, [histone H3]-trimethyl-L-lysine(4) demethylase 5A, RBBP-2
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR12742] (AB177486)
Intracellular flow cytometric analysis of permeabilized NCCIT cells labeling KDM5A / Jarid1A / RBBP2 with ab177486 at 1/10 dilution (red) or a rabbit IgG (negative) (green).
- IP
Lab
Immunoprecipitation - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR12742] (AB177486)
KDM5A / Jarid1A / RBBP2 was immunoprecipitated from 0.35 mg NIH/3T3 (mouse embryonic fibroblast) whole cell lysate with ab177486 at 1/30 dilution (2µg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab177486 at 1/1000 dilution.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
This blot was developed using a high-sensitivity ECL substrate, allowing for the detection of proteins in the mid-femtogram range.
All lanes:
Immunoprecipitation - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR12742] (ab177486) at 1/30 dilution
Lane 1:
3T3-L1 (mouse embryonic fibroblast) transfected with scrambled siRNA control whole cell lysate at 7 µg
Lane 2:
3T3-L1 transfected with scrambled siRNA control whole cell lysate
Lane 3:
Rabbit monoclonal IgG (<a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a>) instead of <a href='/en-us/products/primary-antibodies/kdm5a-jarid1a-rbbp2-antibody-epr18651-ab194286'>ab194286</a> in 3T3-L1 transfected with scrambled siRNA control lysate
Lane 4:
3T3-L1 transfected with siRNA specifically targeting KDM5A whole cell lysate at 7 µg
Lane 5:
3T3-L1 transfected with siRNA specifically targeting KDM5A whole cell lysate
Lane 6:
Rabbit monoclonal IgG (<a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a>) instead of <a href='/en-us/products/primary-antibodies/kdm5a-jarid1a-rbbp2-antibody-epr18651-ab194286'>ab194286</a> in 3T3-L1 transfected with siRNA specifically targeting KDM5A lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Observed band size: 200 kDa
true
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR12742] (AB177486)
All lanes:
Western blot - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR12742] (ab177486) at 1/1000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
293T cell lysate at 10 µg
Lane 3:
MCF7 cell lysate at 10 µg
Lane 4:
NCCIT cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 192 kDa
false
- WB
Lab
Western blot - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR12742] (AB177486)
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : KDM5A knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa whole cell lysate (20 μg)
Lane 4 : HEK293 whole cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab177486 observed at 240 kDa. Red - loading control, ab18058, observed at 130 kDa.
ab177486 was shown to specifically react with KDM5A in wild-type HAP1 cells. No bands were observed when KDM5A knockout samples were used. Wild-type and KDM5A knockout samples were subjected to SDS-PAGE. ab177486 and ab18058 (Mouse anti Vinculin loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR12742] (ab177486)
Predicted band size: 192 kDa
false
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR12742] (AB177486)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 K-562 (human chronic myelogenous leukemia lymphoblast) cells and 5 µg of ab177486 [EPR12742]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR12742] (AB177486)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 K-562 (human chronic myelogenous leukemia lymphoblast) cells and 5 µg of ab177486 [EPR12742]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR12742] (AB177486)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 K-562 (human chronic myelogenous leukemia lymphoblast) cells and 5 µg of ab177486 [EPR12742]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
Related conjugates and formulations (1)
-
Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR12742] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
BMC complementary and alternative medicine 18:193 PubMed29933759
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com